Minor oxygenated cannabinoids from high potency Cannabis sativa L
- Phytochemistry. 2015 Sep:117:194-199. doi: 10.1016/j.phytochem.2015.04.007.
- 1. National Center for Natural Products Research, School of Pharmacy, The University of Mississippi, University, MS 38677, United States; Department of Pharmacognosy, Faculty of Pharmacy, Suez Canal University, Ismailia, Egypt.
- 2. National Center for Natural Products Research, School of Pharmacy, The University of Mississippi, University, MS 38677, United States; Department of Pharmacognosy, School of Pharmacy, The University of Mississippi, University, MS 38677, United States. Electronic address: [email protected].
- 3. National Center for Natural Products Research, School of Pharmacy, The University of Mississippi, University, MS 38677, United States.
- 4. National Center for Natural Products Research, School of Pharmacy, The University of Mississippi, University, MS 38677, United States; Department of Pharmacognosy, Faculty of Pharmacy, Alexandria University, Alexendria, Egypt.
- 5. National Center for Natural Products Research, School of Pharmacy, The University of Mississippi, University, MS 38677, United States; Department of Pharmacognosy, School of Pharmacy, The University of Mississippi, University, MS 38677, United States.
- 6. National Center for Natural Products Research, School of Pharmacy, The University of Mississippi, University, MS 38677, United States; Department of Pharmaceutics, School of Pharmacy, The University of Mississippi, University, MS 38677, United States. Electronic address: [email protected].
Nine oxygenated cannabinoids were isolated from a high potency Cannabis sativa L. variety. Structure elucidation was achieved using spectroscopic techniques, including 1D and 2D NMR, HRMS and GC-MS. These minor compounds include four hexahydrocannabinols, four tetrahydrocannabinols, and one hydroxylated cannabinol, namely 9α-hydroxyhexahydrocannabinol, 7-oxo-9α-hydroxyhexa-hydrocannabinol, 10α-hydroxyhexahydrocannabinol, 10aR-hydroxyhexahydrocannabinol, Δ(9)-THC aldehyde A, 8-oxo-Δ(9)-THC, 10aα-hydroxy-10-oxo-Δ(8)-THC, 9α-hydroxy-10-oxo-Δ(6a,10a)-THC, and 1'S-hydroxycannabinol, respectively. The latter compound showed moderate anti-MRSa (IC50 10.0 μg/mL), moderate antileishmanial (IC50 14.0 μg/mL) and mild antimalarial activity against Plasmodium falciparum (D6 clone) and P. falciparum (W2 clone) with IC50 values of 3.4 and 2.3 μg/mL, respectively.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: Cannabinoid ReceptorResearch Areas: Neurological Disease
-
target: Drug DerivativeResearch Areas: Others